
Commentary: Don't overlook Stage 0 cancer. It could be your earliest warning sign
LONDON: At 71, Tina Knowles – the fashion designer, businesswoman, and mother of Beyonce – made headlines not for her career, but for a deeply personal revelation: Her breast cancer diagnosis. In 2023, a routine mammogram uncovered two tumours in her left breast, one benign and the other malignant. Diagnosed with Stage 1 breast cancer, she underwent surgery and is now cancer-free.
Knowles had initially hesitated to share her story, even considering leaving it out of her upcoming memoir Matriarch. A private person by nature, she ultimately chose to speak out to educate and inspire others – especially women balancing busy lives – about the critical importance of regular screenings.
Knowles candidly revealed that her cancer might have been caught even earlier, at Stage 0, if she hadn't missed a mammogram during the COVID pandemic. Like many, she delayed rescheduling, and it wasn't until nearly four years later that she returned for screening.
Her sister, a breast cancer survivor herself, reminded her that if she had stayed on schedule, doctors might have detected her cancer before it had begun to invade surrounding tissue.
Thankfully, Knowles' tumour was small and slow-growing. Still, the experience shook her and reinforced a message she now shares widely: Early detection saves lives.
IS 'STAGE 0 CANCER' CANCER?
Knowles' story opens the door to an important medical conversation: What exactly is Stage 0 cancer, and why does it matter?
Stage 0, often called 'carcinoma in situ', is the earliest form of cancer. The Latin phrase in situ means 'in its original place', and that's exactly where these abnormal cells remain – they haven't yet spread to nearby tissue or other parts of the body. In breast cancer, the most common type of Stage 0 is ductal carcinoma in situ (DCIS), where abnormal cells are confined to the milk ducts.
Because Stage 0 cancers rarely cause symptoms or lumps, they're usually detected through screening – most often, a mammogram. In fact, the breast is where Stage 0 is most commonly diagnosed, thanks to the effectiveness of these screening programmes.
But Stage 0 cancer is not unique to the breast. Similar early, non-invasive changes can be found in other organs, such as the cervix (cervical intraepithelial neoplasia) or the colon (certain types of polyps).
There's a growing debate in the medical community about whether Stage 0 cancers should be labelled as 'cancer' at all. Some experts argue that terms like 'pre-cancer' or 'non-invasive cancer' might better reflect the low risk posed by these abnormal cells. Others caution that, while not invasive yet, some Stage 0 cancers can become dangerous over time, especially if left untreated.
Research suggests that up to 40 per cent of untreated DCIS cases may eventually develop into invasive breast cancer, although the risk in any given year is relatively low at around 3 per cent. Because we currently lack a reliable way to predict which cases will progress, most doctors recommend treatment such as surgery to remove abnormal cells.
POWER OF EARLY DETECTION
Treatment for Stage 0 cancer is typically less aggressive than for more advanced stages, but it's still personalised. In breast cancer, options often include:
Lumpectomy – surgery to remove only the affected area
Mastectomy – removal of the entire breast
Radiation therapy – often recommended after lumpectomy to reduce the risk of recurrence
Hormone therapy – for cancers that have hormone receptors, medication may be used to lower future risk.
However, some experts are exploring a different approach: Active surveillance. This strategy involves closely monitoring low-grade lesions without immediate treatment. While promising for some patients, it's still controversial since there's always a risk the cancer could progress silently.
The prognosis for Stage 0 cancer is overwhelmingly positive. The five-year survival rate for Stage 0 breast cancer approaches 99 per cent and most people diagnosed at this stage will never experience a recurrence.
This remarkable outcome is a testament to the power of early detection and effective treatment. However, the rise in Stage 0 diagnoses also raises questions about so-called over-diagnosis and over-treatment and whether this means some people are undergoing unnecessary procedures for abnormalities that might never have caused harm.
ROUTINE CARE IS IMPORTANT
Despite its early stage, a diagnosis of Stage 0 cancer can carry a heavy emotional toll. There's comfort in knowing the cancer was caught early but also anxiety about what might have happened if it hadn't. Many patients struggle with the uncertainty of whether treatment was necessary or whether watchful waiting would have been safe.
Knowles, for instance, spoke of disbelief, fear and the emotional rollercoaster that followed her diagnosis. She credits her daughters and friends for getting her through, providing love, laughter and perspective in a frightening time. Her openness underscores how vital it is to have a strong support system and a healthcare team that encourages open dialogue.
Mammograms and other screening tools like colonoscopies are vital for catching cancers at the earliest, most treatable stages. While the increase in Stage 0 diagnoses has fuelled debate about over-treatment, it's clear that early detection gives people options and a chance at a cure before cancer becomes more aggressive.
My research team is working to develop more effective methods for distinguishing which early abnormalities truly require treatment and which can be safely monitored. Until those tools are widely available, public health experts continue to stress one clear message: Stay up to date with recommended screenings.
Knowles' story is more than a celebrity health headline, it's a powerful reminder that prioritising routine care can change the course of your life. Stage 0 cancer represents a rare window of opportunity: A chance to intervene early, often with excellent outcomes. But it also requires careful decision-making, emotional resilience and support.
The message is simple and urgent: Take care of yourself. Reschedule that appointment. Get screened. It might just save your life.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


AsiaOne
2 hours ago
- AsiaOne
US CDC continues to recommend Covid-19 vaccines for children, contradicts Kennedy, World News
The US Centres for Disease Control and Prevention said Covid-19 vaccines remain an option for healthy children when parents and doctors agree that it is needed, stopping short of Health Secretary Robert F. Kennedy Jr.'s announcement that the agency would remove the shots from its immunization schedule. In a schedule published late on Thursday (May 27), the CDC said any Covid-19 vaccination in healthy children aged 6 months to 17 years should follow "shared clinical decision-making" between a child's parents and their healthcare provider. It had previously recommended updated Covid-19 vaccines for everyone aged six months and older, following the guidance of its panel of outside experts. "Where the parent presents with a desire for their child to be vaccinated, children 6 months and older may receive Covid-19 vaccination, informed by the clinical judgment of a healthcare provider and personal preference and circumstances," the CDC notice said. It provides instructions for administering the shots to healthy children by age group, from infants to teenagers. Kennedy, a long-time vaccine skeptic who oversees the CDC, the Food and Drug Administration and the National Institutes of Health, had said on Tuesday the recommendations would be dropped. "As of today, the Covid-19 vaccine for healthy children and healthy pregnant women has been removed from the CDC recommended immunization schedule," Kennedy said in a video posted on the X platform. A spokesperson for the Department of Health and Human Services said there was no contradiction between Kennedy's statement and the CDC schedule, which no longer provides a broad recommendation for healthy children. Kennedy's announcement prompted criticism from medical experts who said the health secretary circumvented the government's decision-making process on vaccines and could prevent health insurance coverage for Covid-19 shots to vulnerable Americans. The Infectious Diseases Society of America said on Tuesday that removing the recommendation "does the opposite of what Americans have been asking for when it comes to their health - it takes away choices and will negatively impact them." It added infants and children may "develop severe disease and may suffer from prolonged symptoms due to long Covid-19, which can negatively impact their development." [[nid:718567]] Nearly 1,900 children up to 18 years of age died of Covid0-19 in the US, according to CDC estimates updated in 2023. The makers of Covid-19 vaccines available in the US - Pfizer, Moderna and Novavax - did not immediately respond to requests for comment. Traditionally, the CDC's Advisory Committee for Immunization Practices would meet and vote on changes to the immunization schedule or recommendations on who should get vaccines before the agency's director made a final call. The committee had not voted on the changes announced by Kennedy. Last week, the FDA said it plans to require new clinical trials for approval of annual Covid-19 boosters for healthy Americans under 65, effectively limiting them to older adults and those at risk of developing severe illness.

Straits Times
10 hours ago
- Straits Times
US CDC keeps recommendation of Covid-19 vaccines for healthy kids
US Health Secretary Robert F. Kennedy Jr had earlier said the CDC would stop recommending routine Covid-19 vaccines for healthy children and pregnant women. PHOTO: REUTERS US CDC keeps recommendation of Covid-19 vaccines for healthy kids WASHINGTON - The US Centres for Disease Control and Prevention is still recommending Covid-19 vaccines for healthy children, according to its latest published immunisation schedule. The schedule, published late on May 29 by the public health agency, comes after Health and Human Services Secretary Robert F. Kennedy Jr - alongside the heads of the FDA and the National Institutes of Health - earlier this week said the CDC would stop recommending routine Covid-19 vaccines for healthy children and pregnant women. The makers of Covid-19 vaccines sold in the US - Pfizer, Moderna and Novavax - did not immediately respond to Reuters' requests for comment. Mr Kennedy Jr, FDA commissioner Marty Makary and NIH director Jay Bhattacharya had said in a video that the shots were removed from the CDC's recommended immunisation schedule. The CDC, following its panel of outside experts, previously recommended updated Covid-19 vaccines for everyone aged six months and older, and current recommendations are in line with those made before. REUTERS Join ST's Telegram channel and get the latest breaking news delivered to you.

Straits Times
10 hours ago
- Straits Times
US CDC keeps recommendation of COVID vaccines for healthy kids
Moderna logo is seen displayed in this illustration taken, May 3, 2022. REUTERS/Dado Ruvic/Illustration US CDC keeps recommendation of COVID vaccines for healthy kids WASHINGTON - The U.S. Centers for Disease Control and Prevention is still recommending COVID-19 vaccines for healthy children, according to its latest published immunization schedule. The schedule, published late on Thursday by the public health agency, comes after Health and Human Services Secretary Robert F. Kennedy Jr. — alongside the heads of the FDA and the National Institutes of Health — earlier this week said the CDC would stop recommending routine COVID vaccines for healthy children and pregnant women. The makers of COVID vaccines sold in the U.S. — Pfizer, Moderna and Novavax — did not immediately respond to Reuters' requests for comment. Kennedy Jr., FDA commissioner Marty Makary and NIH director Jay Bhattacharya had said in a video that the shots were removed from the CDC's recommended immunization schedule. The CDC, following its panel of outside experts, previously recommended updated COVID vaccines for everyone aged six months and older, and current recommendations are in line with those made before. REUTERS Join ST's Telegram channel and get the latest breaking news delivered to you.